Author: Maayan.elias

BIO INTERNATIONAL convention in San Diego on 6/2022

Dr. Maayan Elias Robicsek will be attending the BIO INTERNATIONAL convention in San Diego on 6.2022 and will be available for meetings. Drop us an email or send Pepticom a meeting request in the BIO partnering system.

Pepticom at the 14th Annual Drug Discovery to Development Innovation Forum

Dr. Immanuel Lerner will be speaking at the 14th Annual Drug Discovery to Development Innovation Forum. We are delighted to announce that our CEO and co-founder, Dr. Immanuel Lerner will be speaking at the 14th Annual Drug Discovery to Development Innovation Forum. This event is the leading pharmaceutical R&D summit for pharma decision-makers, bringing together […]

We are very excited to share our feature article in Nature Portfolio.

Titled, “Breakthrough Technologies Transform the Discovery and Development of Peptide Drugs.” The article looks at how Pepticom designs ab initio novel peptide drug candidates using proprietary AI-driven biocomputational software. You can read the whole article here:https://lnkd.in/gc3G-Shh #drugdiscovery #artificialintelligence #drugdiscovery

Immanuel our CEO will be coming to Boston

an exciting joint venture between Harvard Business School and 8400 – The Health Network. He will be available for meetings on November 2-5.  Please be in touch with Immanuel Lerner, Ph.D. or Maayan Elias Robicsek for meeting or collaboration opportunities.

We are thrilled to announce that Dr. Tomi Sawyer, a world leading Key Opinion Leader (KOL) in the field of peptide #drugdiscovery, will be joining the Pepticom Ltd. Scientific Board.

Tomi is renowned for the discovery of two FDA-approved drugs, including Scenesse®️ (marketed by Clinuvel) and Iclusig®️ (marketed by Takeda) as well as scientific contribution to the design of macrocyclic peptides, including ALRN-6924 (currently in Phase II clinical trials by Aileron Therapeutics). Tomi has also been credited with ~600 scientific publications, patents, and presentations and […]

With over 6,000 active Israeli startups in the #startupnation

Each and every mention and recognition we receive is an honor. Thank you to 2Scots – Marketing for Israeli Startups and Darren Gladstone for featuring Pepticom in their roundup of 100 Startups. You can read more about this amazing project here:https://lnkd.in/eVaJKRV

Deep Pharma Intelligence just released this 𝐀𝐫𝐭𝐢𝐟𝐢𝐜𝐢𝐚𝐥 𝐈𝐧𝐭𝐞𝐥𝐥𝐢𝐠𝐞𝐧𝐜𝐞 𝐢𝐧 𝐃𝐫𝐮𝐠 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲: 𝐅𝐨𝐜𝐮𝐬 𝐨𝐧 𝐎𝐧𝐜𝐨𝐥𝐨𝐠𝐲 report

which features @Pepticom among an amazing ecosystem of biotech companies and technology developers who are applying advanced data analytics and knowledge extraction technologies to drug discovery. Thank you for including us! You can access it via the link: https://lnkd.in/d7pDUwQ